Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (831-840 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|July 18, 2022
Lymphoid blast crisis after prolonged treatment-free remission in chronic myeloid leukaemia after tyrosine kinase inhibitor de-escalation during the COVID-19 pandemicDaniele Avenoso, Dragana Milojkovic, James Clark, et al.
Ejhaem|July 18, 2022
Cryoprecipitate as an alternative to platelet transfusion in thrombocytopeniaPhilip Crispin, Sarah Hicks, Lucy A Coupland, et al.
Ejhaem|July 18, 2022
Cholecystectomy in a patient with paroxysmal nocturnal haemoglobinuria undergoing ravulizumab maintenance treatmentMitsuru Moriyama, Yasuo Aota, Masahiro Okabe, et al.
Ejhaem|July 18, 2022
Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry-based cohort studyKonstantinos Liapis, Georgios Vrachiolias, Vasileios Papadopoulos, et al.
Ejhaem|July 18, 2022
Plasma thymus and activation-regulated chemokine (TARC) as diagnostic marker in pediatric Hodgkin lymphomaEline A M Zijtregtop, Friederike Meyer-Wentrup, Wai-Chu Wong, et al.
Ejhaem|July 18, 2022
Low serum albumin is an independent risk factor in elderly patients with aggressive B-cell lymphoma: Results from prospective trials of the German High-Grade Non-Hodgkin's Lymphoma Study GroupKarin Hohloch, Marita Ziepert, Lorenz Truemper, et al.
Ejhaem|July 18, 2022
PD1 expression on bone marrow T-cells in newly diagnosed Egyptian AML patients: Correlation with hematological parameters, aberrant antigens expression, and response to induction therapyNoha Bassiouny, Nour El-Hoda, Ibtesam M Khalifa, et al.
Ejhaem|July 18, 2022
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect<sup>®</sup> MDS/AML Disease RegistryDaniel A Pollyea, Tracy I George, Mehrdad Abedi, et al.
Ejhaem|July 18, 2022
Primary autoimmune myelofibrosis: A case report in a childZufit Hexner-Erlichman, Joanne Yacobovich, Philippe Trougouboff, et al.
Ejhaem|July 18, 2022
Paroxysmal nocturnal hemoglobinuria-phenotype cells predict a good response to eltrombopag in patients with refractory aplastic anemiaKen Ishiyama, Keijiro Sato, Tatsuya Imi, et al.
Pageof 93

Showing results (831-840 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|July 18, 2022
Lymphoid blast crisis after prolonged treatment-free remission in chronic myeloid leukaemia after tyrosine kinase inhibitor de-escalation during the COVID-19 pandemicDaniele Avenoso, Dragana Milojkovic, James Clark, et al.
Ejhaem|July 18, 2022
Cryoprecipitate as an alternative to platelet transfusion in thrombocytopeniaPhilip Crispin, Sarah Hicks, Lucy A Coupland, et al.
Ejhaem|July 18, 2022
Cholecystectomy in a patient with paroxysmal nocturnal haemoglobinuria undergoing ravulizumab maintenance treatmentMitsuru Moriyama, Yasuo Aota, Masahiro Okabe, et al.
Ejhaem|July 18, 2022
Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry-based cohort studyKonstantinos Liapis, Georgios Vrachiolias, Vasileios Papadopoulos, et al.
Ejhaem|July 18, 2022
Plasma thymus and activation-regulated chemokine (TARC) as diagnostic marker in pediatric Hodgkin lymphomaEline A M Zijtregtop, Friederike Meyer-Wentrup, Wai-Chu Wong, et al.
Ejhaem|July 18, 2022
Low serum albumin is an independent risk factor in elderly patients with aggressive B-cell lymphoma: Results from prospective trials of the German High-Grade Non-Hodgkin's Lymphoma Study GroupKarin Hohloch, Marita Ziepert, Lorenz Truemper, et al.
Ejhaem|July 18, 2022
PD1 expression on bone marrow T-cells in newly diagnosed Egyptian AML patients: Correlation with hematological parameters, aberrant antigens expression, and response to induction therapyNoha Bassiouny, Nour El-Hoda, Ibtesam M Khalifa, et al.
Ejhaem|July 18, 2022
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect<sup>®</sup> MDS/AML Disease RegistryDaniel A Pollyea, Tracy I George, Mehrdad Abedi, et al.
Ejhaem|July 18, 2022
Primary autoimmune myelofibrosis: A case report in a childZufit Hexner-Erlichman, Joanne Yacobovich, Philippe Trougouboff, et al.
Ejhaem|July 18, 2022
Paroxysmal nocturnal hemoglobinuria-phenotype cells predict a good response to eltrombopag in patients with refractory aplastic anemiaKen Ishiyama, Keijiro Sato, Tatsuya Imi, et al.
Pageof 93